BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33902103)

  • 1. The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits.
    Bellomo TR; Jeakle MA; Meyerhoff ME; Bartlett RH; Major TC
    ASAIO J; 2021 May; 67(5):573-582. PubMed ID: 33902103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.
    Major TC; Brisbois EJ; Jones AM; Zanetti ME; Annich GM; Bartlett RH; Handa H
    Biomaterials; 2014 Aug; 35(26):7271-85. PubMed ID: 24927680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer.
    Major TC; Brant DO; Reynolds MM; Bartlett RH; Meyerhoff ME; Handa H; Annich GM
    Biomaterials; 2010 Apr; 31(10):2736-45. PubMed ID: 20042236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
    Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
    Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation.
    Skrzypchak AM; Lafayette NG; Bartlett RH; Zhou Z; Frost MC; Meyerhoff ME; Reynolds MM; Annich GM
    Perfusion; 2007 May; 22(3):193-200. PubMed ID: 18018399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Diazeniumdiolated Dialkylhexanediamines as Nitric Oxide Release Agents on Nonthrombogenicity in an Extracorporeal Circulation Model.
    Jeakle MM; Major TC; Meyerhoff ME; Bartlett RH
    ACS Appl Bio Mater; 2020 Jan; 3(1):466-476. PubMed ID: 35019463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model.
    Major TC; Brant DO; Burney CP; Amoako KA; Annich GM; Meyerhoff ME; Handa H; Bartlett RH
    Biomaterials; 2011 Sep; 32(26):5957-69. PubMed ID: 21696821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemocompatibility Comparison of Biomedical Grade Polymers Using Rabbit Thrombogenicity Model for Preparing Nonthrombogenic Nitric Oxide Releasing Surfaces.
    Handa H; Major TC; Brisbois EJ; Amoako KA; Meyerhoff ME; Bartlett RH
    J Mater Chem B; 2014 Feb; 2(8):1059-1067. PubMed ID: 24634777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved hemocompatibility of silicone rubber extracorporeal tubing via solvent swelling-impregnation of S-nitroso-N-acetylpenicillamine (SNAP) and evaluation in rabbit thrombogenicity model.
    Brisbois EJ; Major TC; Goudie MJ; Bartlett RH; Meyerhoff ME; Handa H
    Acta Biomater; 2016 Jun; 37():111-9. PubMed ID: 27095484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
    Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
    Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Handa H; Brisbois EJ; Major TC; Refahiyat L; Amoako KA; Annich GM; Bartlett RH; Meyerhoff ME
    J Mater Chem B; 2013 Aug; 1(29):3578-3587. PubMed ID: 23914297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and in vivo performance of nitric oxide-releasing extracorporeal circuits in a feline model of thrombogenicity.
    Goudie MJ; Brainard BM; Schmiedt CW; Handa H
    J Biomed Mater Res A; 2017 Feb; 105(2):539-546. PubMed ID: 27741554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
    Suades R; Padró T; Vilahur G; Badimon L
    Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
    Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicity.
    Jerez-Dolz D; Torramade-Moix S; Palomo M; Moreno-Castaño A; Lopez-Vilchez I; Hernandez R; Badimon JJ; Zafar MU; Diaz-Ricart M; Escolar G
    Atherosclerosis; 2020 Feb; 294():17-24. PubMed ID: 31945614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model.
    Fallon BP; Lautner-Csorba O; Major TC; Lautner G; Harvey SL; Langley MW; Johnson MD; Saveski C; Matusko N; Rabah R; Rojas-Pena A; Meyerhoff ME; Bartlett RH; Mychaliska GB
    Pediatr Res; 2024 Jan; 95(1):93-101. PubMed ID: 37087539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric detection of circulating platelet-derived microparticles in healthy adult horses.
    Springer NL; Smith E; Brooks MB; Stokol T
    Am J Vet Res; 2014 Oct; 75(10):879-85. PubMed ID: 25255176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
    Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
    Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.
    Major TC; Handa H; Annich GM; Bartlett RH
    J Biomater Appl; 2014 Oct; 29(4):479-501. PubMed ID: 24934500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.